Young or adult users of multiple tobacco/nicotine products urgently need to be informed of meaningful differences in product risks

Addictive Behaviors

Volumn 76, Issue , 2018, Pages 376-381

  Kozlowski, Lynn T ^a   Sweanor, David T ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Risk communication; Smokeless tobacco; Tobacco prevention; Tobacco smoking

Indexed keywords

NICOTINE;

CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; ELECTRONIC CIGARETTE; FOOD AND DRUG ADMINISTRATION; HEALTH LITERACY; HUMAN; INFORMED CONSENT; LONGITUDINAL STUDY; MEDICAL INFORMATION; NORWAY; NOTE; OBSERVATIONAL STUDY; RISK ASSESSMENT; SMOKELESS TOBACCO; SMOKING; SMOKING REGULATION; TERTIARY PREVENTION; UNITED STATES; ADOLESCENT; ADULT; PROCEDURES; PUBLIC HEALTH; RISK; SMOKING PREVENTION; TOBACCO; TOBACCO DEPENDENCE;

ADOLESCENT; ADULT; HEALTH COMMUNICATION; HUMANS; PUBLIC HEALTH; RISK; SMOKING PREVENTION; TOBACCO PRODUCTS; TOBACCO USE DISORDER;

EID: 85010960773     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2017.01.026     Document Type: Note

References (64)

1. Agaku, I.T., Singh, T., Rolle, I.V., Ayo-Yusuf, O.A., Exposure and response to current text-only smokeless tobacco health warnings among smokeless tobacco users aged >/=18 years, United States, 2012–2013. Preventive Medicine 87 (2016), 200–206.
2. American Cancer Society Action Network, FDA action imperative as youth use of E-cigarettes, hookah skyrockets. News Releases & Statements, Vol. 2016, 2015 April 16, 2015. Retrieved August 25, 2016, from http://www.acscan.org/content/media-center/fda-action-imperative-as-youth-use-of-e-cigarettes-hookah-skyrockets/.
3. Bell, K., Keane, H., All gates lead to smoking: The ‘gateway theory’, e-cigarettes and the remaking of nicotine. Social Science and Medicine 119 (2014), 45–52.
4. Beyth-Marom, R., Austin, L., Fischhoff, B., Palmgren, C., Jacobs-Quadrel, M., Perceived consequences of risky behaviors: Adults and adolescents. Developmental Psychology 29 (1993), 549–563.
5. Chaloupka, F.J., Sweanor, D., Warner, K.E., Differential taxes for differential risks—Toward reduced harm from nicotine-yielding products. New England Journal of Medicine 373 (2015), 594–597.
6. Colilla, S.A., An epidemiologic review of smokeless tobacco health effects and harm reduction potential. Regulatory Toxicology and Pharmacology 56 (2010), 197–211.
7. Damphousse, K.E., Mowls, D.S., Beebe, L.A., An ecological analysis of tobacco use and oral cavity and pharynx cancers in U.S. males. Journal - Oklahoma State Medical Association 108 (2015), 488–491.
8. Dave, D., Saffer, H., Demand for smokeless tobacco: Role of advertising. Journal of Health Economics 32 (2013), 682–697.
9. Degenhardt, L., Dierker, L., Chiu, W.T., Medina-Mora, M.E., Neumark, Y., Sampson, N., Kessler, R.C., Evaluating the drug use “gateway” theory using cross-national data: Consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug and Alcohol Dependence 108 (2010), 84–97.
10. Fischhoff, B., Brewer, N.T., Downs, J.S., Communicating risks and benefits: An evidence-based user's guide. 2001, Food and Drug Administration (FDA), US Department of Health and Human Services, 234.
11. Gao, H., Prasad, G.L., Zacharias, W., Combusted but not smokeless tobacco products cause DNA damage in oral cavity cells. Environmental Toxicology and Pharmacology 37 (2014), 1079–1089.
12. Gostin, L.O., Public health law: Power, duty, restraint. 2nd ed., 2008, University of California Press, Berkeley, CA, USA.
13. Johnston, L.D., Miech, R.A., O'Malley, P.M., Bachman, J.G., Schulenberg, J.E., Use of alcohol, cigarettes, and number of illicit drugs declines among U.S. teens. 2014, University of Michigan News Service, Ann Arbor, MI.
14. Johnston, L.D., O'Malley, P.M., Schulenberg, J.E., Miech, R.A., Monitoring the Future national survey results on drug use, 1975–2013: Volume I, secondary school students. 2014, Institute for Social Research, The University of Michigan, Ann Arbor.
15. Kaufman, A.R., Land, S., Parascandola, M., Augustson, E., Backinger, C.L., Tobacco use transitions in the United States: The National Longitudinal Study of Adolescent Health. Preventive Medicine 81 (2015), 251–257.
16. Kiviniemi, M.T., Kozlowski, L.T., Deficiencies in public understanding about tobacco harm reduction: Results from a United States national survey. Harm Reduction Journal, 12, 2015, 21, 10.1186/s12954-015-0055-0.
17. Kleinig, J., Ready for retirement: The gateway drug hypothesis. Substance Use and Misuse 50 (2015), 971–975.
18. Kowitt, S.D., Patel, T., Ranney, L.M., Huang, L.-L., Sutfin, E.L., Goldstein, A.O., Poly-tobacco use among high school students. International Journal of Environmental Research and Public Health 12 (2015), 14477–14489.
19. Kozlowski, L., Strasser, A., Giovino, G., Erickson, P., Terza, J., Applying the risk/use equilibrium: Use medicinal nicotine now for harm reduction. Tobacco Control, 10, 2001, 201.
20. Kozlowski, L.T., Effect of smokeless tobacco product marketing and use on population harm from tobacco use: Policy perspective for tobacco-risk reduction. American Journal of Preventive Medicine 33 (2007), S379–S386.
21. Kozlowski, L.T., Prospects for a nicotine-reduction strategy in the cigarette endgame: Alternative tobacco harm reduction scenarios. International Journal on Drug Policy 26 (2015), 543–547 http://dx.doi.org/10.1016/j.drugpo.2015.02.001.
22. Kozlowski, L.T., Vaping as a ‘gateway’ to smoking is still more hype than hazard. The Conversation, 2015 September 24, 2015. Retrieved August 25, 2016, from https://theconversation.com/vaping-as-a-gateway-to-smoking-is-still-more-hype-than-hazard-47399 http://www.webcitation.org/6k1nsWVeT.
23. Kozlowski, L.T., Abrams, D.B., Obsolete tobacco control themes can be hazardous to public health: The need for updating views on absolute product risks and harm reduction. BMC Public Health, 16, 2016, 432, 10.1186/s12889-016-3079-9.
24. Kozlowski, L.T., O'Connor, R.J., Apply federal research rules on deception to misleading health information: An example on smokeless tobacco and cigarettes. Public Health Reports, 118, 2003, 187.
25. Kozlowski, L.T., Sweanor, D., Withholding differential risk information on legal consumer nicotine/tobacco products: The public health ethics of health information quarantines. International Journal on Drug Policy 32 (2016), 17–23 http://dx.doi.org/10.1016/j.drugpo.2016.03.014.
26. Levy, D.T., Cummings, K.M., Villanti, A.C., Niaura, R., Abrams, D.B., Fong, G.T., Borland, R., A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine products. Addiction 112 (2017), 8–17.
27. Liu, S.T., Nemeth, J.M., Klein, E.G., Ferketich, A.K., Kwan, M.P., Wewers, M.E., Risk perceptions of smokeless tobacco among adolescent and adult users and nonusers. Journal of Health Communication 20 (2015), 599–606.
28. Lund, I., Lund, K.E., How has the availability of snus influenced cigarette smoking in Norway?. International Journal of Environmental Research and Public Health 11 (2014), 11705–11717.
29. Lund, K.E., Association between willingness to use snus to quit smoking and perception of relative risk between snus and cigarettes. Nicotine & Tobacco Research 14 (2012), 1221–1228.
30. Macy, J.T., Li, J., Xun, P., Presson, C.C., Chassin, L., Dual trajectories of cigarette smoking and smokeless tobacco use from adolescence to midlife among males in a Midwestern US community sample. Nicotine & Tobacco Research 18 (2016), 186–195.
31. McNeill, A., B., L., Calder, R., Hitchman, S.C., Hajek, P., McRobbie, H., E-cigarettes: An evidence update. 2015, Public Health England.
32. Mejia, A.B., Ling, P.M., Tobacco industry consumer research on smokeless tobacco users and product development. American Journal of Public Health 100 (2010), 78–87.
33. Messer, K., Vijayaraghavan, M., White, M.M., Shi, Y., Chang, C., Conway, K.P., Pierce, J.P., Cigarette smoking cessation attempts among current US smokers who also use smokeless tobacco. Addictive Behaviors 51 (2015), 113–119.
34. Millstein, S.G., Halpern-Felsher, B.L., Perceptions of risk and vulnerability. Journal of Adolescent Health 31 (2002), 10–27.
35. Myers, M.L., Surgeon general carmona rejects claims smokeless tobacco is a safer alternative to cigarettes. Campaign for Tobacco-free Kids: Campaign for Tobacco-free Kids, Vol. 2016, 2003.
36. Naik, G., Ahmed, H., Edwards, A.G.K., Communicating risk to patients and the public. The British Journal of General Practice 62 (2012), 213–216.
37. National Center for Chronic Disease Prevention and Health Promotion, The health consequences of smoking-50 years of progress: A report of the surgeon general. 2014, Centers for Disease Control and Prevention (US), Atlanta (GA).
38. Nutt, D.J., Phillips, L.D., Balfour, D., Curran, H.V., Dockrell, M., Foulds, J., Sweanor, D., Estimating the harms of nicotine-containing products using the MCDA approach. European Addiction Research 20 (2014), 218–225.
39. O'Connor, R.J., Non-cigarette tobacco products: What have we learnt and where are we headed?. Tobacco Control 21 (2012), 181–190.
40. Office of Management and Budget, Guidelines for ensuring and maximizing the quality, objectivity, utility, and integrity of information disseminated by Federal agencies. Office of the President, (eds.) Republication, Vol. 67, 2002, Federal Register, Washington, DC, 8452–8460.
41. Phillips, C.V., Gateway effects: Why the cited evidence does not support their existence for low-risk tobacco products (and what evidence would). International Journal of Environmental Research and Public Health 12 (2015), 5439–5464.
42. Piano, M.R., Benowitz, N.L., Fitzgerald, G.A., Corbridge, S., Heath, J., Hahn, E., Howard, G., Impact of smokeless tobacco products on cardiovascular disease: Implications for policy, prevention, and treatment: A policy statement from the American Heart Association. Circulation 122 (2010), 1520–1544.
43. Reyna, V.F., Farley, F., Risk and rationality in adolescent decision making - Implications for theory, practice, and public policy. Psychological Science, 2006, 1–44.
44. Rivers, S.E., Reyna, V.F., Mills, B., Risk taking under the influence: A fuzzy-trace theory of emotion in adolescence. Developmental Review 28 (2008), 107–144.
45. Rodu, B., Cole, P., Evidence against a gateway from smokeless tobacco use to smoking. Nicotine & Tobacco Research 12 (2010), 530–534.
46. Rousu, M.C., O'Connor, R.J., Thrasher, J.F., June, K.M., Bansal-Travers, M., Pitcavage, J., The impact of product information and trials on demand for smokeless tobacco and cigarettes: Evidence from experimental auctions. Preventive Medicine 60 (2014), 3–9.
47. Royal College of Physicians, Nicotine without smoke: Tobacco harm reduction. 2016, RCP, London.
48. Scientific Committee on Emerging and Newly Identified Health Risks, Scientific opinion on the health effects of smokeless tobacco products. 2008 Retrieved December 20, 2016 from http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_013.pdf.
49. Scott, E.S., Wollard, J.L., The legal regulation of adolescence. Lerner, R.M., Steinberg, L., (eds.) Handbook of adolescent psychology, 2013, John Wiley & Sons, Inc., Hoboken, NJ, USA, 523–550.
50. Steinberg, L., A social neuroscience perspective on adolescent risk-taking. Developmental Review 28 (2008), 78–106.
51. Steinberg, L., Cauffman, E., Maturity of judgment in adolescence: Psychosocial factors in adolescent decision making. Law and Human Behavior 20 (1996), 249–272.
52. Strasser, A.A., Orom, H., Tang, K.Z., Dumont, R.L., Cappella, J.N., Kozlowski, L.T., Graphic-enhanced information improves perceived risks of cigar smoking. Addictive Behaviors 36 (2011), 865–869.
53. Stratton, K.R., Clearing the smoke: Assessing the science base for tobacco harm reduction. 2001, Institute of Medicine, National Academy Press, Washington, D.C.
54. Tam, J., Day, H.R., Rostron, B.L., Apelberg, B.J., A systematic review of transitions between cigarette and smokeless tobacco product use in the United States. BMC Public Health, 15, 2015, 258.
55. Tobacco Companies Are Told to Correct Lies About Smoking, The New York Times. November 28, 2012, The New York Times Company, New York, N.Y., B8.
56. Tomar, S.L., Alpert, H.R., Connolly, G.N., Patterns of dual use of cigarettes and smokeless tobacco among US males: Findings from national surveys. Tobacco Control 19 (2010), 104–109.
57. U.S. Department of Health and Human Services, O. o. D. P. a. H. P, National action plan to improve health literacy. 2010 (Washington, DC).
58. U.S. National Library of Medicine, FDA launches ad campaign against chewing tobacco: Health officials targeting rural teens with messages about health risks of smokeless tobacco products. HealthDay: Medline Plus, Vol. 2016, 2016.
59. Vanyukov, M.M., Ridenour, T.A., Common liability to drug addictions: Theory, research, practice. Drug and Alcohol Dependence 123:Suppl. 1 (2012), S1–S2.
60. Vanyukov, M.M., Tarter, R.E., Kirillova, G.P., Kirisci, L., Reynolds, M.D., Kreek, M.J., Ridenour, T.A., Common liability to addiction and “gateway hypothesis”: Theoretical, empirical and evolutionary perspective. Drug and Alcohol Dependence 123:Suppl. 1 (2012), S3–17.
61. Wackowski, O.A., Delnevo, C.D., Young adults' risk perceptions of various tobacco products relative to cigarettes: Results from the national young adult health survey. Health Education and Behavior 43 (2016), 328–336.
62. Weed, S.E., Sex education programs for schools still in question: A commentary on meta-analysis. American Journal of Preventive Medicine 42 (2012), 313–315.
63. Weitkunat, R., Sanders, E., Lee, P.N., Meta-analysis of the relation between European and American smokeless tobacco and oral cancer. BMC Public Health, 7, 2007, 334.
64. Zeller, M., Reflections on the ‘endgame’ for tobacco control. Tobacco Control 22 (2013), i40–i41.